Humana Inc. (HUM)
| Market Cap | 51.86B +44.7% |
| Revenue (ttm) | 145.68B +18.3% |
| Net Income | 1.28B -18.8% |
| EPS | 10.59 -18.8% |
| Shares Out | 120.08M |
| PE Ratio | 40.79 |
| Forward PE | 34.78 |
| Dividend | $3.54 (0.82%) |
| Ex-Dividend Date | Oct 30, 2026 |
| Volume | 4,993,488 |
| Open | 450.49 |
| Previous Close | 387.12 |
| Day's Range | 428.45 - 456.50 |
| 52-Week Range | 163.11 - 456.50 |
| Beta | 0.74 |
| Analysts | Buy |
| Price Target | 452.87 (+4.86%) |
| Earnings Date | Nov 6, 2026 |
About HUM
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and... [Read more]
Financial Performance
In 2025, Humana's revenue was $129.66 billion, an increase of 10.11% compared to the previous year's $117.76 billion. Earnings were $1.19 billion, a decrease of -1.57%.
Financial StatementsAnalyst Summary
According to 26 analysts, the average rating for HUM stock is "Buy." The 12-month stock price target is $452.87, which is an increase of 4.86% from the latest price.
News
Humana rises 12.8%
Humana (HUM) is up 12.8%, or $49.48 to $436.60.
Friday's First Moves: CRWD & ZS Pirce Target Hikes, HUM Upgrade
Baird is now a bull in Humana (HUM) over greater confidence in the company's 2028 EPS goal. Diane King Hall explains why the note is significant for the rising healthcare company.
Humana Stock Jumps on Raised Medicare Advantage Ratings
Humana shares are soaring after the health insurer said it received improved star ratings for a number of its Medicare Advantage plans.
Humana rises 14.7%
Humana (HUM) is up 14.7%, or $56.87 to $443.99.
SpaceX initiated, Humana upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by…
5 Things to Know Before the Stock Market Opens on Friday
Stock futures are pointing to a higher open Friday as the major indexes look to lock in a week of gains; shares of AT&T, T-Mobile and Verizon are falling after SpaceX took another step towards becomin...
Humana Says 95% of Medicare Advantage Members in 4-Star Plans for 2027
Humana said 95% of its Medicare Advantage members are enrolled in plans rated at least four stars for 2027, an improvement that could make more of its membership eligible for quality-related bonus pay...
Humana surges after emerging as top beneficiary of 2027 Medicare star ratings
Humana's shares rose 15% in premarket trading on Friday after analysts said the health insurer is the biggest beneficiary of the new star ratings for 2027 Medicare Advantage plans.
SpaceX, Verizon, Delta, Humana, and More Stocks That Explain Today's Market
SpaceX stock is rising, while AT&T, Verizon, and T-Mobile shares are falling as investors fret Elon Musk's aerospace company will muscle into telecom.
Humana up 15% to $444.50 after reporting improved Star Ratings for 2027
06:17 EDT Humana (HUM) up 15% to $444.50 after reporting improved Star Ratings for 2027
Humana announces improved Star Ratings for 2027
Humana (HUM) announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare…
Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, hi...
Humana price target raised to $582 from $515 at Barclays
Barclays raised the firm’s price target on Humana (HUM) to $582 from $515 and keeps an Overweight rating on the shares. The company recovered all of its large 3.5 star…
Humana upgraded to Outperform from Neutral at Baird
Baird upgraded Humana (HUM) to Outperform from Neutral with a price target of $596, up from $390. The firm now has greater confidence in the company’s $35-plus of 2028 adjusted…
Managed Care Organization stock moving after CMS releases Star ratings
CVS Health (CVS) is down almost 5% in after-hours trading, UnitedHealth (UNH) fell over 1%, and Alignment Healthcare (ALHC) dropped over 20%, while Humana (HUM) soared 15% Other publicly traded…
Humana jumps, Alignment Healthcare slips after CMS releases Star ratings
CMS stated: CMS publishes the MA – Medicare Part C – and Part D Star Ratings each year to measure the quality of health and prescription drug services received by…
Humana up 16% after CMS release of latest Star ratings
Shares of Humana (HUM) are up 16% to $450.02 in after-hours trading.
Humana Faces Medicare ‘Stars' Rating. The Result Will Test the Stock.
Improving Medicare Advantage ratings isn't easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.
Cantor upgrades Humana into this week’s stars announcement
Cantor Fitzgerald upgraded Humana (HUM) to Overweight from Neutral with a price target of $460, up from $300. The firm cites higher confidence in Humana’s Medicare margin and stars recovery…
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence ...
Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana's contributions across the s...
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients
LOUISVILLE, Ky.--(BUSINESS WIRE)--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.
Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company's annual nationwide day of service. In its third year, Humana Community ...